Loading clinical trials...
Loading clinical trials...
This is a Phase II randomized, double-masked study comparing the safety and efficacy of ATG003 (mecamylamine HCl) 1.0% and 0.3% ophthalmic solutions to placebo in patients with neovascular ("wet") age...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CoMentis
NCT05803785 · Age-Related Macular Degeneration
NCT07392255 · Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT07550777 · Diabete Mellitus, Retina Vein Occlusion, and more
NCT07440225 · Macular Degeneration, Age-Related Macular Degeneration, and more
NCT05407636 · AMD, nAMD, and more
Hospital de Olhos de Araraquara
Araraquara
Centro Brasileiro de Ciências Visuais
Belo Horizonte
Instituto da Visão
Belo Horizonte
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions